Needham & Company Downgrades Regulus Therapeutics (RGLS) to Hold

Go back to Needham & Company Downgrades Regulus Therapeutics (RGLS) to Hold

Form 8-K Regulus Therapeutics For: Jan 27

January 27, 2017 4:53 PM EST

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

... More

Form S-8 Regulus Therapeutics

January 27, 2017 4:51 PM EST

As filed with the Securities and Exchange Commission on January 27, 2017

Registration No. 333-            

 

 

 

... More